Triangulation Bulls Eye and Stone Direct Targeting Pcnl
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04846699 |
|
Recruitment Status :
Not yet recruiting
First Posted : April 15, 2021
Last Update Posted : April 15, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
To assess the impact of percutaneous renal access technique on outcomes of percutaneous nephrolithotomy in management of renal stones by comparing the Triangulation and ''eye of the needle'' (or bull's eye) and the stone targeted techniques in the following:-
- Stone free rate (SFR) (primary outcome).
- Complicatins of surgery (primary outcome).
- Change in haematocrit pre and postoperative (secondary outcome).
- Operative time (secondary outcome).
- Duration of hospitalization (secondary outcome). .
7-Fluroscpic screening time (FST) (secondary outcome). . 8- Change in haematocrit pre and postoperative (secondary outcome).
| Condition or disease | Intervention/treatment |
|---|---|
| Endourology | Procedure: per-cutaneous stone extraction |
Percutaneous nephrolithotomy (PNL) is an appropriate first-line alternative for the management of kidney stones that are larger than 2 cm in diameter and that do not respond to extracorporeal shock wave lithotripsy (SWL) [1,2].
Percutaneous renal access is the most important step in PNL, and the adequacy of access directly affects the success and complication rates of this procedure.
Among C-arm fluoroscopy, computed tomography (CT), and ultrasonography (US), C-arm fluoroscopy is the most commonly used imaging technique to access the intrarenal collecting system [3-4].
Various fluoroscopy techniques have been described for achieving a good access. One can use fluoroscopy or ultrasonography or a combination of both for reaching the target calyx. Each of it has its advantages and disadvantages, and no consensus exists showing the superiority of one or the other [5].
Triangulation and ''eye of the needle'' (or bull's eye) techniques are two common methods to obtain proper percutaneous renal access under fluoroscopy guidance [6-7].
Multiplanar fluoroscopic imaging is essential in both techniques to make a proper renal puncture.
Biplanar access is based on mediolateral and cephalad-caudal movements of the needle, with the depth of the puncture adjusted based on different fluoroscopic projections, including oblique, vertical, and 30° positions [6, 8].
Most published studies of PCNL have focused on evaluating the effect of patient- and stone-related factors such as success rate, extent of bleeding, complication rate, fluoroscopic Screening times (FSTs), and operative time on outcomes. [9-10]
The imaging modalities used for guidance by urologists or radiologists during percutaneous renal access and renal access procedures have also recently been analyzed and compared in terms of outcomes and complications.[11-12]
These studies, however, have not considered the effect of percutaneous renal access technique on outcome. Although the triangulation and the bull's-eye techniques have been evaluated and compared using a biologic model in a published study [13], no clinical study comparing these techniques has been performed.
The aim of this study is to evaluate the impact of percutaneous renal access technique on outcomes of percutaneous nephrolithotomy in management of renal stones by comparing the Triangulation and ''eye of the needle'' (or bull's eye) and the stone targeted technique .
| Study Type : | Observational |
| Estimated Enrollment : | 150 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Triangulation, Eye of the Needle and Stone Direct Targeting Percutaneous Renal Access Techniques of Nephrolithotomy : Randomized Controlled Trial |
| Estimated Study Start Date : | April 20, 2021 |
| Estimated Primary Completion Date : | April 20, 2023 |
| Estimated Study Completion Date : | April 20, 2023 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
group 1
bulls eye localization
|
Procedure: per-cutaneous stone extraction
percutaneous nephrolithotripsy for renal stones by different renal access |
|
group 2
stone targeted technique renal access
|
Procedure: per-cutaneous stone extraction
percutaneous nephrolithotripsy for renal stones by different renal access |
|
group 3
triangulation renal access technique
|
Procedure: per-cutaneous stone extraction
percutaneous nephrolithotripsy for renal stones by different renal access |
- stone free rate [ Time Frame: 48 hours postoperative ]outcome of residual stone postoperative
- complication of surgery [ Time Frame: from day one post-operative to 3 months ]fever , urine leakage , stent of ureter , sepsis, other intervention
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years to 60 Years (Adult) |
| Sexes Eligible for Study: | All |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- The study will include all adult patients that with renal stones larger than 2 cm in diameter who will attend our endourology outpatient clinic from Jan 2021 to February 2023 and consented to participate in the study.
Exclusion Criteria:
- 1-Patients with urinary system anomalies as horseshoe kidney, ectopic pelvic kid.
2-Patients with skeletal malformations. 3-Bleeding tendency and ongoing anticoagulant therapy. 4-Pregnancy. 5-Patients who refuse to be involved in the trial documentation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04846699
| Contact: mahmoud abdo eldardery | 01008763519 | m.eldardery91@gmail.com |
| Egypt | |
| NIH | |
| Assiut, Egypt, 20892 | |
| Responsible Party: | mahmoud eldardery, dr mahmoud abdo el dardery, Assiut University |
| ClinicalTrials.gov Identifier: | NCT04846699 |
| Other Study ID Numbers: |
new pcnl approch |
| First Posted: | April 15, 2021 Key Record Dates |
| Last Update Posted: | April 15, 2021 |
| Last Verified: | April 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

